Lymph Nodes, Tumor Deposits, and TNM: Are We Getting Better?

Author:

Nagtegaal Iris D.1,Tot Tibor1,Jayne David G.1,McShane Phil1,Nihlberg Anders1,Marshall Helen C.1,Påhlman Lars1,Brown Julia M.1,Guillou Pierre J.1,Quirke Philip1

Affiliation:

1. Iris D. Nagtegaal, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands; Tibor Tot, Anders Nihlberg, Falu Lasarett, Falun; Lars Påhlman, Uppsala University, Uppsala, Sweden; David G. Jayne, Pierre J. Guillou, St James University Hospital; Philip Quirke, Leeds Institute of Molecular Medicine; Phil McShane, Helen C. Marshall, Julia M. Brown, University of Leeds, Leeds, United Kingdom.

Abstract

PurposeNew editions of the TNM staging system for colorectal cancer have been subject to extensive criticism. In the current study, we evaluate each edition of TNM and analyze stage migration caused by the different versions.Patients and MethodsTwo independent test populations were used: participants derived from a randomized surgical trial from the United Kingdom (n = 455) and patients from a population-based series from Sweden (n = 505). All slides from these patient cases were reviewed with special attention for the presence of tumor deposits. Tumor deposits were classified according to the fifth, sixth, and seventh editions of TNM and correlated with prognosis.ResultsEvery change in edition of TNM led to a stage migration of between 33% and 64% in patients with tumor deposits. Reproducibility was best in the fifth edition of TNM. The prognostic value of the seventh edition was best only when all tumor deposits irrespective of size or contour were included as lymph nodes. The prognostic value of the fifth edition was better than that of the sixth.ConclusionWe demonstrate there is a place for tumor deposits in the staging of patients with colorectal cancer. However, many questions remain about their definition and the reproducibility and use of this category in special situations, such as after neoadjuvant treatment. These should be the subject of additional research before use as a factor in TNM staging. This work demonstrates the necessity of testing modifications before their introduction.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3